Document quand l'auteur est "Sureau, Camille"Nombre de documents archivés : 7. ArticleBlanchet, Matthieu; Angelo, Léna; Tetreault, Yasmine; Khabir, Marwa; Sureau, Camille; Vaillant, Andrew et Labonté, Patrick ORCID: https://orcid.org/0000-0001-7262-3125 (2024). HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression Viruses , vol. 16 , nº 4:532. pp. 1-16. DOI: 10.3390/v16040532. Khabir, Marwa; Aliche, Asma Zahra; Sureau, Camille; Blanchet, Matthieu et Labonté, Patrick ORCID: https://orcid.org/0000-0001-7262-3125 (2020). HDV alters the autophagy process to promote its genome replication Journal of Virology , vol. 94 , nº 4. pp. 1-16. DOI: 10.1128/JVI.01936-19. Khabir, Marwa; Aliche, Asma Zahra; Sureau, Camille; Blanchet, Matthieu et Labonté, Patrick ORCID: https://orcid.org/0000-0001-7262-3125 (2020). Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication Journal of virology , vol. 94 , nº 4. pp. 1-16. DOI: 10.1128/JVI.01936-19. Blanchet, Matthieu; Sureau, Camille; Guévin, Carl; Seidah, Nabil G. et Labonté, Patrick (2015). SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection Antiviral Research , vol. 115 . pp. 94-104. DOI: 10.1016/j.antiviral.2014.12.017. Blanchet, Matthieu; Sureau, Camille et Labonté, Patrick (2014). Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle Antiviral Research , vol. 106 . pp. 111-115. DOI: 10.1016/j.antiviral.2014.03.017. Document issu d'une conférence ou d'un atelierBlanchet, Matthieu; Angelo, Léna; Tetreault, Yasmine; Khabir, Marwa; Sureau, Camille; Vaillant, Andrew et Labonté, Patrick ORCID: https://orcid.org/0000-0001-7262-3125 (2023). An in Vitro Culture Model for The Induction of HDV Replication in a HBV Expressing Cell Line In: Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), November 10-14, 2023, Boston, MA. Blanchet, Matthieu; Sureau, Camille et Labonté, Patrick . Identification d’inhibiteurs du NTCP capables de bloquer l’infection d’hepatocytes par les virus des l’hépatites B et Delta In: 8e édition, Congrès Armand-Frappier 2013, 14-16 novembre 2013, Orford (Québec). |